Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Lok Chung Chan
Age : 69
Country of residence : Unknown
Linked companies : Apellis Pharmaceuticals, Inc. - Hang Lung Group Limited - Stealth BioTherapeutics Corp

Summary 
Dr. Lok Chung Chan is a Chairman at Vesigen, Inc., a Chairman at Apellis Pharmaceuticals, Inc., a Member-Global Advisory Council at The International Society for Stem Cell Research, a Chairman at Stealth BioTherapeutics Corp., a Chairman at Morningside Group Ltd., a Chairman at The Chinese University of Hong Kong, a Chairman-Overseers Board at Morningside College, a Member at Massachusetts General Hospital Cancer Center and a Member-International Governors Board at New York Academy of Sciences.

He is on the Board of Directors at LumiraDx Ltd., The Scripps Research Institute, Stealth BioTherapeutics, Inc., Hang Lung Group Ltd., Canopy Education, Inc., MatriVAX, Inc., Morningside Foundation, Synchroneuron, Inc., Vaccine Technologies, Inc. and Fudan University. Dr. Chan was previously employed as an Independent Director by Aduro BioTech, Inc., a Co-Founder by Morningside Group Ltd. (United States), a Co-Founder by Morningside Venture Investments Ltd., a Member by Council on Foreign Relations, Inc., and a Non-Executive Director by NuCana Plc.

He also served on the board at PhoreMost Ltd., Natural Polymer International Corp., Advanced Cell Diagnostics, Inc., Critical Biologics Corp., Inimex Pharmaceuticals, Inc., InSilixa, Inc., Kezar Life Sciences, Inc., MetaCure (USA), Inc., Oxyrane UK Ltd. and Serica Technologies, Inc.

He received his undergraduate degree from the University of California, Los Angeles, a graduate degree from the University of California, Los Angeles, a graduate degree from Harvard University and a doctorate degree from Harvard University.




Current positions of Lok Chung Chan 
Holdings of Lok Chung Chan 
Lok Chung Chan : Personal Network 
Most Read News 
06/14ELON MUSK : Bitcoin tops $40,000 after Musk says Tesla could use it again
RE
06/07JEFF BEZOS : Amazon's billionaire founder Jeff Bezos to fly to space next month
RE
06/04JACK DORSEY : Square considering making bitcoin hardware wallet -Dorsey
RE
06/02BILL GATES : Bill Gates' next generation nuclear reactor to be built in Wyoming
RE
06/12JEFF BEZOS : Bid of $28 million wins a rocket trip to space with Bezos
RE
06/08CHAMATH PALIHAPITIYA : Palihapitiya's $16 million bet on Clover worth $682 million on Reddit rally
RE
06/04WILLIAM ACKMAN : Ackman reinvents SPAC in Universal Music deal talks
RE
06/11ELON MUSK : 'This car crushes' Musk says, as Tesla launches faster Model S 'Plaid'
RE
06/15JACK MA : Alibaba executive says founder Jack Ma 'lying low' - CNBC
RE
06/10MARIA MARTINEZ : French Industrial Production Unexpectedly Declined in April
DJ
More news


© 2021 People and Ownership :   
Lok Chung Chan : Connections 


Latest news about Lok Chung Chan 
2016Premier United Group Limited completed the acquisition of an additional 28.58% stake in EPI Limited from its shareholders for approximately HKD 210 million.
CI
2016Premier United Group Limited made an offer to acquire remaining 72.24% stake in EPI Limited from Citigroup Inc., Banking and Securities Investments and others for approximately HKD 530 million.
CI
More news